B. Müller-Beckmann

发表

Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensives

M. Hennig, C. Staiger, L. Widmann, 2005, European Journal of Clinical Pharmacology.

Effect of 17β-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17β-estradiol serum kinetics and bone mass in rats

F. Bauss, G. Sponer, B. Müller-Beckmann, 1996, Calcified Tissue International.

Studies on the Mode of Vasodilating Action of Carvedilol*

K. Strein, G. Sponer, B. Müller-Beckmann, 1987, Journal of cardiovascular pharmacology.

Receptor pharmacology of carvedilol in the human heart.

J. Port, M. Bristow, D. Handwerger, 1992, Journal of cardiovascular pharmacology.

Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes

J. Port, M. Bristow, D. Handwerger, 2004, The clinical investigator.

Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.

R. Ziegler, J. Pfeilschifter, W. Blum, 1995, The Journal of clinical investigation.

Activation of Counter-Regulatory Mechanisms on Administration of Equipotent Doses of Different Types of Vasodilators to Conscious Dogs

K. Strein, G. Sponer, B. Müller-Beckmann, 1985 .

Hemodynamic Profile of BM 14.478: A New Positive Inotropic and Vasodilating Agent

K. Strein, G. Sponer, B. Müller-Beckmann, 1988, Journal of cardiovascular pharmacology.

Ca2+-sensitizing effect of BM 14.478 on skinned cardiac muscle fibres of guinea-pig papillary muscle.

K. Strein, J. Rüegg, L. Kling, 1987, European journal of pharmacology.

Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs

G. Sponer, L. Kling, A. Dorszewski, 1990, British journal of pharmacology.

Effects of Isosorbide-5-Mononitrate on Hemodynamic Parameters and on Regional Myocardial Ischemia in Conscious Dogs

K. Strein, G. Sponer, B. Müller-Beckmann, 1985 .

Pharmacological Profile of Carvedilol as a β-Blocking Agent with Vasodilating and Hypotensive Properties

K. Strein, G. Sponer, B. Müller-Beckmann, 1987, Journal of cardiovascular pharmacology.

Pharmacological Profile of Carvedilol, a Compound with &bgr;‐Blocking and Vasodilating Properties*

K. Strein, G. Sponer, B. Müller-Beckmann, 1987, Journal of cardiovascular pharmacology.

Effects of carvedilol on ventricular arrhythmias.

R. Senior, R. van der Does, A. Lahiri, 1992, Journal of cardiovascular pharmacology.

The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.

F. H. Schmidt, H. Patscheke, K. Stegmeier, 1984, Thrombosis research.

Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.

H. Patscheke, C. Staiger, G. Neugebauer, 1984, Biomedica biochimica acta.

Nonsteroidal cardiotonics. 3. New 4,5-dihydro-6-(1H-indol-5-yl)pyridazin-3(2H)-ones and related compounds with positive inotropic activities.

W. G. Friebe, A. Mertens, W. von der Saal, 1990, Journal of medicinal chemistry.

Nonsteroidal cardiotonics. 2. The inotropic activity of linear, tricyclic 5-6-5 fused heterocycles.

A. Mertens, W. von der Saal, B. Müller-Beckmann, 1989, Journal of medicinal chemistry.

Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents.

A. Mertens, W. von der Saal, B. Müller-Beckmann, 1987, Journal of medicinal chemistry.

Mode of Vasodilating Activity of Carvedilol in Isolated Perfused Hind Limbs of Rabbits

K. Strein, G. Sponer, L. Kling, 1988, Drugs.

Naftopidil, a New Adrenoceptor Blocking Agent with Ca2+-Antagonistic Properties: Interaction with Adrenoceptors

H. Borbe, G. Sponer, B. Müller-Beckmann, 1992, Journal of cardiovascular pharmacology.

New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate.

F. Bauss, R. Schenk, Robert K Schenk, 2004, Journal of pharmacological and toxicological methods.

Effect of the new matrix metalloproteinase inhibitor RO-28-2653 on mitochondrial function.

Stephan Zierz, S. Zierz, F. Gellerich, 2002, Biochemical pharmacology.

Isosorbide-5-Mononitrate Increases Cyclic Guanosine Monophosphate Concentration in Rat Aorta in Vitro and in Vivo

K. Strein, G. Sponer, B. Müller-Beckmann, 1985 .

Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.

K. Strein, G. Sponer, B. Müller-Beckmann, 1984, The Journal of pharmacology and experimental therapeutics.

Pharmacological characteristics of the stereoisomers of carvedilol

K. Strein, H. Borbe, U. Martin, 2005, European Journal of Clinical Pharmacology.

The Non-Prostanoid BM 13.177 Inhibits Vasoconstriction at the Thromboxane Receptor Level

H. Patscheke, K. Stegmeier, G. Sponer, 1985 .

Blood Pressure Recording in Rats: Pitfalls and Problems1

U. Martin, G. Sponer, B. Müller-Beckmann, 1993 .

In Vitro Investigations on a New Positive Inotropic and Vasodilating Agent (BM 14.478) That Increases Myocardial Cyclic AMP Content and Myofibrillar Calcium Sensitivity

L. Kling, P. Honerjäger, P. Freund, 1988, Journal of Cardiovascular Pharmacology.

Abstract of the 68th Meeting (Spring Meeting) 6–9 March 1990, Heidelberg

A. Konnerth, B. Sakmann, P. Jonas, 1990, Pflügers Archiv.

Vasodilatory action of carvedilol.

K. Strein, G. Sponer, B. Müller-Beckmann, 1992, Journal of cardiovascular pharmacology.

Effective thrombolysis by a recombinant Escherichia coli-produced protease domain of tissue-type plasminogen activator in the rabbit model of jugular vein thrombosis

K. Stegmeier, S. Fischer, A. Stern, 1996 .